Key facts
- This page summarizes Sarah Taylor Anderson's Form 4 filing for SelectQuote, Inc. (SLQT).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 26 Feb 2025, 17:07.
Sarah Taylor Anderson - 20 Feb 2025 Form 4 Insider Report for SelectQuote, Inc. (SLQT)
- Reporting relationship
- Executive Vice President, Healthcare
- Issuer ticker
- SLQT
- Reported as of
- 20 Feb 2025
- Net transaction value
- -$272,000
- SEC form
- 4
- Accepted by SEC
- 26 Feb 2025, 17:07:15 UTC
- Prior SEC filing
- 30 Oct 2024
- Next SEC filing
- 04 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Daniel A. Boulware, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Sarah Taylor Anderson filed Form 4 for SelectQuote, Inc. (SLQT) on 26 Feb 2025.
Change
- Previous filing in this sequence was filed on 30 Oct 2024.
- Current net transaction value: -$272,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SLQT
transaction
Common Stock, par value $0.01 per share
Options Exercise
- Transaction value
- $28,125
- Shares
- +15,000
- Change %
- +41%
- Price
- $1.88
- Shares after
- 51,166
- Date
- 20 Feb 2025
- Ownership
- Direct
SLQT
transaction
Common Stock, par value $0.01 per share
Sale
- Transaction value
- $272,000
- Shares
- -50,000
- Change %
- -98%
- Price
- $5.44
- Shares after
- 1,166
- Date
- 20 Feb 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SLQT
transaction
Derivative
Employee Stock Options
Options Exercise
- Transaction value
- $28,125
- Shares
- -15,000
- Change %
- -88%
- Price
- $1.88
- Shares after
- 2,000
- Date
- 20 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock, par value $0.01 per share
- Underlying amount
- 15,000
- Exercise price
- $1.88
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 3 footnotes
Footnote F1
Amount reported represents a weighted average price. On February 20, 2025, Ms. Anderson sold 50,000 shares in multiple transactions at prices ranging from $5.37 to $5.74, inclusive. The reporting person undertakes to provide to SelectQuote, Inc. (the "Company"), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
Footnote F2
Represents incentive stock options of the Company granted to the recipient pursuant to the Company's 2003 Stock Incentive Plan. Each option represents the contingent right to purchase one share of the Company's common stock, par value $0.01 per share, at a predetermined price specified in Column 8 of this table.
Footnote F3
The option vests ratably in three annual installments commencing on the one-year anniversary of the grant date, February 8, 2018, subject to the recipient's continued employment with the Company through the applicable vesting date.
SEC remarks
Executive Vice President, Healthcare